Bone Marrow Transplantation: A Journey From Despair to Hope
Keywords:
oncology, bone marrow transplantation,
Abstract
The devastation caused by nuclear warfare in 1945 provoked an urgency to study the effects of irradiation on the human body. High doses or lethal irradiation causes bone marrow failure and without a functioning bone marrow, long-term survival is not possible. Experimentation on bone marrow transplantation was initially done on animals and slowly progressed to humans. The first attempts were unsuccessful and many believed that attempts to transplant bone marrow in human beings were not justified. However, the pressing need for a viable treatment option for a variety of haematological disorders continued. As successful reports of transplants from HLA-identical siblings in children emerged, researches were encouraged to continue their efforts. Gradually, with increased knowledge, new technologies and improved results, there has been a rapid increase in bone marrow transplantation worldwide, suggesting that a curative option has become a reality. Blood or marrow stem cell transplantation involves the transfer of stem cells to establish haematopoiesis (blood formation). Unlike the transfusion of blood products whose benefits are temporary, stem cells are intended to survive long-term. Haematopoietic stem cells can be obtained from the bone marrow, peripheral blood or from umbilical cord blood. The donor may be the patient (autograft), a matched sibling (allograft) or an matched, unrelated donor.
Published
2008-03-20
Issue
Section
Oncology Nursing
By submitting manuscripts to PNT, authors of original articles are assigning copyright to Medpharm Publications (Pty) Ltd. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in PNT for educational and research purposes without obtaining permission.